Obinutuzumab as salvage anti-CD20 therapy in poly-refractory difficult-to-treat seropositive rheumatoid arthritis. [PDF]
Monjo-Henry I +7 more
europepmc +1 more source
ABSTRACT This study examines the impact of EU Directive 2014/95/EU (NFRD) on the Environmental, Social and Governance (ESG) performance of EU‐listed companies, focusing on variations across ESG dimensions and national institutional contexts. Using a dataset of 19,036 observations from 2010 to 2022, we apply a time‐varying Difference‐in‐Differences ...
Yuqing Xiao, Antonio Somoza
wiley +1 more source
Strategic Approaches to ESG Reporting: Analysing ESG Disclosures of Listed Companies
ABSTRACT This study adopts an exploratory approach to examine how firms communicate strategic orientation through ESG disclosures. Using a validated dictionary of exploration and exploitation language, we analyse 278 ESG reports from all UAE‐listed companies between 2020 and 2023, classifying ESG disclosures as exploration‐dominant, exploitation ...
Cintia Külzer‐Sacilotto +1 more
wiley +1 more source
The diagnostic role of albumin-based ratio markers for periprosthetic joint infection. [PDF]
Fan P +6 more
europepmc +1 more source
Transformative improvement with staggered gains in rheumatoid arthritis remission and sustained remission, but higher relapse rates: a population-based cohort study from 1990 to 2019. [PDF]
El Hasbani G +5 more
europepmc +1 more source
Laboratory Markers Associated with Deep Neck Infection in Emergency Department Patients with Throat or Neck Symptoms. [PDF]
Shin JH, Kim TY, Lee JS.
europepmc +1 more source
Evaluating disease activity scores and CBC-derived indices in relation to osteoporosis risk in rheumatoid arthritis: a cross-sectional analysis. [PDF]
Jin D +7 more
europepmc +1 more source

